ReviewGene therapy2025
Is dystrophin immunogenicity a barrier to advancing gene therapy for Duchenne muscular dystrophy?
Dariusz C Górecki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ReviewGene therapy2025
Dariusz C Górecki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.